Presentation TCT 2025 Management of Aortic Stenosis PLUS... Concomitant and Multivalvular Heart Disease Presenter: Gilbert H. L. Tang October 26, 2025
Presentation TCT 2025 Low Flow Low Gradient Severe Aortic Stenosis: How Low Is Too Low To Treat? Presenter: Matthew John Czarny October 26, 2025
Presentation TCT 2025 TCT 317: Impact of Very Severe Aortic Stenosis on Periprocedural Stroke Risk After Transcatheter Aortic Valve Replacement Presenter: Jung-Joon Cha October 26, 2025
Presentation TCT 2025 Modern Era and Futuristic Pharmacological Management of Aortic Stenosis: Pre and Post Intervention Presenter: Chetan Huded October 26, 2025
Presentation TCT 2025 TCT 1415: Navigating the Aorta: TAVR in a Patient With Prior EVAR, FEVAR, and Aortic Dissection Presenter: Hunter Edward Launer October 26, 2025
Presentation TCT 2025 TCT 319: Short -Term Clinical Effect of Cerebral Embolic Protection Device Following Transcatheter Aortic-Valve Replacement in Korea Population: The Sentinel Registry (Sentinel) Presenter: Han Su Park October 26, 2025
Presentation TCT 2025 Earlier Detection of Valvular Heart Disease Presenter: Pierre Elias October 26, 2025
Presentation TCT 2025 TCT 318: Stroke after TAVR - Impact on Clinical Outcome and Patient Reported Quality of Life (QoL): The Michigan Structural Heart Consortium (MISHC) Experience Presenter: P. Michael Grossman October 26, 2025
Presentation TCT 2025 Addressing Disparities In Aortic Stenosis Management: Have We Made Progress? Presenter: Wayne Batchelor October 26, 2025
Presentation TCT 2025 TCT 322: Routine Use of Cerebral Embolic Protection Devices During Transcatheter Aortic Valve Replacement: A Meta-Analysis of Randomized Controlled Trials Presenter: Hasan Ilyas October 26, 2025
Presentation TCT 2025 TCT 1412: Transcatheter Aortic Valve Replacement (TAVR) in a Case With Calcified Right-Dominant Double Aortic Arch Presenter: Kuan Yu Lin October 26, 2025
Presentation TCT 2025 TCT 321: Cerebral Embolic Protection Devices in Transcatheter Aortic Valve Replacement: A Meta-Analysis of Randomized Controlled Trials Presenter: Mostafa Ali October 26, 2025
Presentation TCT 2025 How Do I Derisk TAVR in Challenging or Previously Treated Aortic Anatomy Presenter: Oscar A. Mendiz October 26, 2025
Presentation TCT 2025 Addressing Undertreatment In Aortic Stenosis: Target AS, Detect AS, and Beyond Presenter: Sammy Elmariah October 26, 2025
Presentation TCT 2025 TCT 640: Diabetes, Glucose Dysregulation, and Inflammatory Biomarkers as Predictors of Mortality and Adverse Events Following Transcatheter Aortic Valve Implantation: A Systematic Review and Meta-analysis Presenter: Mahsa Rezasoltani October 26, 2025
Presentation TCT 2025 TCT 643: Treatment of Aortic Stenosis in Patients with Active Cancer: Lifetime Management Considerations Presenter: Philipp Kiefer October 26, 2025
Presentation TCT 2025 TCT 644: Impact of Timing of Aortic Valve Replacement Relative to Cancer Therapy on Clinical Outcomes in Patients With Hematologic Malignancy and Severe Aortic Stenosis: A Real‑World Propensity‑Matched Presenter: Hasnan M. Ijaz October 26, 2025
Presentation TCT 2025 TCT 641: 5-Year Outcomes of New Generation Balloon Expandable Valve Replacement in Patients with End-Stage Renal Disease Presenter: Hidemasa Shitan October 26, 2025
Presentation TCT 2025 TCT 75: Repurposing Transthoracic Echocardiogram Predictors of Cardiac Amyloid to Risk Stratify the Severe Aortic Stenosis Population Referred for TAVR Presenter: Robert Kay October 26, 2025